Peer-reviewedCC BYReviews in cardiovascular medicine
Biomarkers and Risk Prediction in Cardiovascular–Kidney–Metabolic Syndrome: A Comprehensive Review
- 1Department of Nephrology, Zhongshan Hospital, Fudan University, 200032 Shanghai, China
Related
- Biomarkers for the diagnosis and management of cardiovascular-kidney-metabolic syndrome: recent advances and prospects for clinical application
- A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study
- Proteomics assisted improvement prediction of risk for adverse cardiovascular events in individuals with metabolic syndrome.
- Depression, functional disability, and cardiovascular disease in adults with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationally representative cohort study
- Association of sleep time with all-cause and cardiovascular mortality among individuals with advanced cardiovascular-kidney-metabolic syndrome : A NHANES-based prospective cohort study
BibTeX
@article{lu2026biomarkers,
title = {{Biomarkers and Risk Prediction in Cardiovascular–Kidney–Metabolic Syndrome: A Comprehensive Review}},
author = {Yuanyuan Lu and Mingxin Yang and Jinbo Yu and Pan Lin and Jun Ji and Xiaoqiang Ding and Yaqiong Wang and Xialian Xu},
journal = {Reviews in cardiovascular medicine},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13653173},
note = {CC BY},
}
RIS
TY - JOUR
TI - Biomarkers and Risk Prediction in Cardiovascular–Kidney–Metabolic Syndrome: A Comprehensive Review
AU - Yuanyuan Lu
AU - Mingxin Yang
AU - Jinbo Yu
AU - Pan Lin
AU - Jun Ji
AU - Xiaoqiang Ding
AU - Yaqiong Wang
AU - Xialian Xu
PY - 2026
DA - 2026/09/01
JO - Reviews in cardiovascular medicine
UR - https://europepmc.org/article/PMC/PMC13653173
SN - 1530-6550
ER -